Clinical Trial

A Study of SKB571 in Participants With Gastrointestinal Tumors

Name: A Study of SKB571 in Participants With Gastrointestinal Tumors — clinical trial record (NCT07564466)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is an open-label, multicenter, phase II study. The purpose of this study is to evaluate the safety, tolerability and preliminary anti-tumor activity of SKB571 in participants with gastrointestinal tumors.

Protocol Amendment History 1 change

critical Recruitment opened 2026-08-05

Trial Details

NCT Number	NCT07564466
Lead Sponsor	Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Conditions	Gastrointestinal Tumors
Enrollment	120 participants
Start Date	2026-05-20
Primary Completion	2027-08-31 (estimated)
Study Completion	2028-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-04